Accelerate to discover

Back to filter

Related topics

Preclinical hyperpolarized carbon-13 magnetic resonance imaging in neurological disease models

Bruker Biospin

Nov 8, 2019

Hyperpolarized (HP)-13C MR is proven as a viable tool for imaging of neurological disorders often associated with...

Imaging Flow Cytometry webinar: aging cells, giant viruses using AMNIS platform

Luminex

Nov 6, 2019

In this webinar we will describe three recent applications for imaging flow cytometry (IFC), a technology that combines...

Webinar recording: Use of ultra-high field MRI for in and ex vivo neuroimaging

Bruker Biospin

Nov 6, 2019

The relatively low T1 contrast, long T1 values at higher fields lead to the necessity to adapt sequences commonly used...

Join the webcast: Addressing cancer gene therapy efficacy with IncuCyte Live–Cell Imaging

Sartorius

Oct 29, 2019

During this webinar, Dr Pierre Cordelier will discuss the use of IncuCyte Live-Cell Imaging and Analysis, to track gene...

Nov 14, 2019

Acquisition and analysis of reproducible high-complexity cytometry data using the Cytek Aurora

Cytek Biosciences

Oct 8, 2019

We invite you to join us on Friday, October 11 at 8:00 PM CET to hear more about Cytek collaborative...

Webinar recording - Highly sensitive structural variant detection for medical genetics

BioNano Genomics

Oct 4, 2019

Follow the webinar outlining how a team at Radboud University Medical Center is assessing ultra-long read optical...

What if NMR was easy? Aspects & applications of the Fourier 80 FT-NMR benchtop spectrometer

Bruker Biospin

Oct 1, 2019

What if there was a NMR instrument everybody could operate, that is as easy to use as infrared spectroscopy and as easy...

Nov 14, 2019

Cytek webinar - the new age of spectral flow cytometry

Cytek Biosciences

Sep 9, 2019

The Cytek Aurora flow cytometer has made more than twenty-four color flow cytometry panels possible with only three...

Show all topics (10)

Next generation karyotyping: detecting cancer-associated structural variants using optical maps

Apr 19, 2017

James Broach, PhD, Penn State Hershey, Pennsylvania, United States.

Identification of structural variants (SVs) is critical to the prognosis of acute myeloid leukemia (AML) and other hematologic malignancies. SVs are not readily identified by next generation sequencing methods and are currently diagnosed by cytogenetics, an intrinsically low resolution tool. Dr. James Broach from Penn State Hershey will discuss a new method for determining large SVs as a clinical tool for evaluating AML and other cancer genomes using Bionano optical mapping. Dr. Broach has applied this technology for detection of SVs in a variety of cancer cell lines and directly from leukemia patient blood samples.  In all cases, they have identified all the SVs reported by classic cytogenetic analysis and, in addition, a large number of translocations, deletions and insertions not observed by cytogenetics.

Register now

Webinar

Related technologies: Genome mapping

Get more info

Regina Fillerová

Field application specialist

Regina

Fillerová

+420 731 127 718

Send Message

Brand profile

BioNano Genomics

A revolutionary NanoChannel technology for Genome mapping of extremely long DNA without amplification, providing long-range contiguity and eliminating PCR bias.

Related products

Genome maps of extremely long DNA without amplification, providing long-range contiguity and eliminating PCR bias

show detail

Saphyr provides rapid, high-throughput, long-range genome mapping with unmatched structural variation discovery capabilities

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey